AMICUS THERAPEUTICS, INC. Insider Trading Activity
Every SEC Form 4 insider transaction reported for AMICUS THERAPEUTICS, INC. (FOLD), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are FOLD insiders buying or selling?
In the last 12 months, AMICUS THERAPEUTICS, INC. insiders reported 0 open-market purchases ($0) and 11 sales ($5.4M) — net selling of $5.4M. Since January 2018, Trabud has recorded 296 Form 4 filings for FOLD: 26 buys ($16.2M) and 270 sells ($68.2M).
Source: SEC EDGAR Form 4
What stands out
- No AMICUS THERAPEUTICS, INC. insider made an open-market purchase in the last 12 months; the 11 reported open-market sales totaled $5.4M.
Key Statistics (January 2018 – Mar 5, 2026)
Total Form 4 filings
296
SEC EDGAR
Insider filers
16
Insider buys (26)
$16.2M
Insider sells (270)
$68.2M
Insider sentiment
Net sellingNet insider flow of $52.0M in net selling since January 2018, and $5.4M in net selling over the last 12 months.
Recent FOLD insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Mar 5, 2026 | Bradley L Campbell | President and CEO | Sale | 22.5K | $14.35 | $322.8K | SEC ↗ |
| Jan 23, 2026 | Bradley L Campbell | President and CEO | Sale | 75.0K | $14.31 | $1.1M | SEC ↗ |
| Dec 23, 2025 | David Michael Clark | Chief People Officer | Sale | 25.6K | $14.17 | $363.4K | SEC ↗ |
| Dec 17, 2025 | Bradley L Campbell | President and CEO | Sale | 77.9K | $10.86 | $846.0K | SEC ↗ |
| Dec 17, 2025 | David Michael Clark | Chief People Officer | Sale | 25.6K | $11.00 | $282.1K | SEC ↗ |
| Dec 4, 2025 | Bradley L Campbell | President and CEO | Sale | 14.6K | $10.01 | $146.0K | SEC ↗ |
| Nov 27, 2025 | Jeff Castelli | Chief Development Officer | Sale | 76.2K | $10.16 | $773.7K | SEC ↗ |
| Nov 27, 2025 | David Michael Clark | Chief People Officer | Sale | 25.6K | $10.10 | $258.9K | SEC ↗ |
| Nov 27, 2025 | Bradley L Campbell | President and CEO | Sale | 14.6K | $10.04 | $146.5K | SEC ↗ |
| Nov 27, 2025 | Ellen Rosenberg | Chief Legal Officer | Sale | 95.6K | $10.02 | $958.5K | SEC ↗ |
| Nov 5, 2025 | David Michael Clark | Chief People Officer | Sale | 25.6K | $9.51 | $243.9K | SEC ↗ |
| Feb 22, 2025 | Bradley L Campbell | President and CEO | Sale | 400 | $10.00 | $4.0K | SEC ↗ |
| Dec 3, 2024 | Bradley L Campbell | President and CEO | Sale | 7.5K | $10.02 | $75.1K | SEC ↗ |
| Nov 7, 2024 | Bradley L Campbell | President and CEO | Sale | 7.9K | $12.50 | $98.8K | SEC ↗ |
| Nov 4, 2024 | Bradley L Campbell | President and CEO | Sale | 7.5K | $11.46 | $86.0K | SEC ↗ |
| Oct 4, 2024 | Bradley L Campbell | President and CEO | Sale | 7.5K | $10.60 | $79.5K | SEC ↗ |
| Sep 5, 2024 | Bradley L Campbell | President and CEO | Sale | 7.5K | $11.71 | $87.8K | SEC ↗ |
| Aug 6, 2024 | Bradley L Campbell | President and CEO | Sale | 7.5K | $10.34 | $77.5K | SEC ↗ |
| Jul 9, 2024 | Bradley L Campbell | President and CEO | Sale | 6.1K | $10.00 | $61.0K | SEC ↗ |
| Jul 3, 2024 | Bradley L Campbell | President and CEO | Sale | 1.4K | $10.00 | $14.0K | SEC ↗ |
| Jun 5, 2024 | Bradley L Campbell | President and CEO | Sale | 7.5K | $10.00 | $75.0K | SEC ↗ |
| May 3, 2024 | Bradley L Campbell | President and CEO | Sale | 7.5K | $10.07 | $75.5K | SEC ↗ |
| Apr 3, 2024 | Bradley L Campbell | President and CEO | Sale | 7.5K | $11.67 | $87.5K | SEC ↗ |
| Mar 15, 2024 | John F Crowley | Executive Chairman | Sale | 31.6K | $13.65 | $431.5K | SEC ↗ |
| Mar 6, 2024 | Margaret G Mcglynn | Director | Sale | 15.0K | $13.35 | $200.2K | SEC ↗ |
Showing the 25 most recent of 296 Form 4 filings for AMICUS THERAPEUTICS, INC..
Most active FOLD insiders
- John F Crowley103 filings
- Bradley L Campbell76 filings
- Burke W Whitman19 filings
- Jay Barth17 filings
- Daphne Quimi11 filings
Ask anything about FOLD insider activity
Use Trabud's AI agent to query AMICUS THERAPEUTICS, INC.'s Form 4 history in plain English — "Show me FOLD CEO purchases this year" or compare it against any other ticker.
Open the AI agentFOLD insider trading FAQ
Are AMICUS THERAPEUTICS, INC. insiders buying or selling?
In the last 12 months, AMICUS THERAPEUTICS, INC. insiders reported 0 open-market purchases ($0) and 11 sales ($5.4M) — net selling of $5.4M. Since January 2018, Trabud has recorded 296 Form 4 filings for FOLD: 26 buys ($16.2M) and 270 sells ($68.2M). Over the full record that is net selling of $52.0M.
How many insiders trade FOLD stock?
16 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for AMICUS THERAPEUTICS, INC.. The most recent filing was accepted on Mar 5, 2026.
Where does Trabud get FOLD insider trading data?
All FOLD insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.